Skip to main content
. 2020 Nov;59(6):737–741. doi: 10.30802/AALAS-JAALAS-19-000155

Table 1.

Noncompartmental pharmacokinetic analysis in dogs treated with Melox-SR (n = 6), Melox-SC (n = 5), and Melox-PO (n = 6)

Melox-SR Melox-SC Melox-PO
Cmax (ng/mL) 2180 551 295
tmax (h) 1 4 4
t1/2 (h) 54.8 NA NA
AUC0–72 (µg × h/mL) 82198 NA NA
AUC0–∞ (µg × h/mL) 99990 NA NA

NA, not applicable